Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

10x Genomics, Inc. (TXG)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsMar-31-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income  -50.7-64.5-42.4-18.4-17.2-11.1-11.6-415.6
Depreciation and amortization  6.56.56.25.85.74.94.83.9
Stock-based compensation  42.136.326.026.926.026.916.214.3
Change in working capital   [+]6.84.3-12.4-12.2-13.6-2.9-14.6-7.1
Other operating activities  -8.80.41.83.8-27.1-14.71.2274.3
Cash from operations  -4.1-17.0-20.85.8-26.23.1-4.1-130.2
   
Capital expenditures  -4.6-27.2-28.1-27.6-20.2-14.6-38.9-21.3
Purchases of intangible assets  -0.7      -0.9
Acquisitions        -5.5 
Purchases of short-term investments, net  125.2-0.3-229.4     
Cash from investing  120.0-27.5-257.6-27.6-20.2-14.6-44.3-22.3
   
Repurchase of common stock, net         -0.8
Option exercises  2.46.47.88.96.716.28.58.5
Financing costs  -5.8 -5.4   -5.00.0
Other cash from financing  -6.812.74.817.813.432.47.017.0
Cash from financing  -3.46.42.48.96.716.23.57.7
   
Free cash flow  -8.7-44.2-48.9-21.8-46.4-11.4-42.9-151.5
        Per share (diluted)  ($0.08)($0.39)($0.43)($0.20)($0.42)($0.10)($0.40)($1.50)
   
Cash paid for interest  0.4 0.8   1.2 
Cash paid for income taxes  2.50.42.90.30.51.06.80.1

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy